Cargando…

Design, Synthesis and SAR Studies of NAD Analogues as Potent Inhibitors towards CD38 NADase

Nicotinamide adenine dinucleotide (NAD), one of the most important coenzymes in the cells, is a substrate of the signaling enzyme CD38, by which NAD is converted to a second messenger, cyclic ADP-ribose, which releases calcium from intracellular calcium stores. Starting with 2′-deoxy-2′-fluoroarabin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shengjun, Zhu, Wenjie, Wang, Xuan, Li, Jianguo, Zhang, Kehui, Zhang, Liangren, Zhao, Yong-Juan, Lee, Hon Cheung, Zhang, Lihe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271716/ https://www.ncbi.nlm.nih.gov/pubmed/25268725 http://dx.doi.org/10.3390/molecules191015754

Ejemplares similares

Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8(+) T cell exhaustion
por: Ma, Kaili, et al.
Publicado: (2022)

Concise Syntheses of Trifluoromethylated Cyclic and Acyclic Analogues of cADPR
por: Huang, Xiangchen, et al.
Publicado: (2010)

CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype
por: de Zélicourt, Antoine, et al.
Publicado: (2022)

The NADase-Negative Variant of the Streptococcus pyogenes Toxin NAD(+) Glycohydrolase Induces JNK1-Mediated Programmed Cellular Necrosis
por: Chandrasekaran, Sukantha, et al.
Publicado: (2016)

NADases as weapons for both plant pathogens and their hosts
por: Ogden, Sam C., et al.
Publicado: (2023)

Structural insights into mechanisms of Argonaute protein-associated NADase activation in bacterial immunity
por: Wang, Xiaoshen, et al.
Publicado: (2023)

Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues
por: Luo, Xiao, et al.
Publicado: (2017)

Synthesis and Calcium Mobilization Activity of cADPR Analogues Which Integrate Nucleobase, Northern and Southern Ribose Modifications
por: Zhou, Yue, et al.
Publicado: (2012)

CD38 is methylated in prostate cancer and regulates extracellular NAD(+)
por: Mottahedeh, Jack, et al.
Publicado: (2018)

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

Discovery of fungal surface NADases predominantly present in pathogenic species
por: Strømland, Øyvind, et al.
Publicado: (2021)

General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
por: Tatsuno, Ichiro, et al.
Publicado: (2022)

Discovery of an NAD(+) analogue with enhanced specificity for PARP1
por: Zhang, Xiao-Nan, et al.
Publicado: (2022)

CD38 regulates ovarian function and fecundity via NAD(+) metabolism
por: Perrone, Rosalba, et al.
Publicado: (2023)

Targeting CD38-dependent NAD(+) metabolism to mitigate multiple organ fibrosis
por: Shi, Bo, et al.
Publicado: (2020)

Mechanism of CD38 via NAD(+) in the Development of Non-alcoholic Fatty Liver Disease
por: Dong, Min, et al.
Publicado: (2023)

NAD(+) exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension
por: Qiu, Yumin, et al.
Publicado: (2023)

Author Correction: Discovery of fungal surface NADases predominantly present in pathogenic species
por: Strømland, Øyvind, et al.
Publicado: (2021)

Plant and prokaryotic TIR domains generate distinct cyclic ADPR NADase products
por: Bayless, Adam M., et al.
Publicado: (2023)

A Novel Fluorescent Cell Membrane-permeable Caged Cyclic ADP-ribose Analogue
por: Yu, Pei-Lin, et al.
Publicado: (2012)

Flavonoid Apigenin Is an Inhibitor of the NAD(+)ase CD38: Implications for Cellular NAD(+) Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome
por: Escande, Carlos, et al.
Publicado: (2013)

Structural basis underlying the synergism of NADase and SLO during group A Streptococcus infection
por: Tsai, Wei-Jiun, et al.
Publicado: (2023)

Macrophage Immunometabolism and Inflammaging: Roles of Mitochondrial Dysfunction, Cellular Senescence, CD38, and NAD
por: Yarbro, Johnathan R., et al.
Publicado: (2020)

NADase and now Ca(2+) channel, what else to learn about plant NLRs?
por: Wan, Li, et al.
Publicado: (2021)

Rhs NADase effectors and their immunity proteins are exchangeable mediators of inter-bacterial competition in Serratia
por: Hagan, Martin, et al.
Publicado: (2023)

Novel Calcium-Binding Motif Stabilizes and Increases the Activity of Aspergillus fumigatus Ecto-NADase
por: Ferrario, Eugenio, et al.
Publicado: (2023)

The new insight into extracellular NAD(+) degradation‐the contribution of CD38 and CD73 in calcific aortic valve disease
por: Jablonska, Patrycja, et al.
Publicado: (2021)

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD(+)-Lowering Agents
por: Becherini, Pamela, et al.
Publicado: (2023)

The SARM1 TIR NADase: Mechanistic Similarities to Bacterial Phage Defense and Toxin-Antitoxin Systems
por: DiAntonio, Aaron, et al.
Publicado: (2021)

Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice
por: Gerasimenko, Maria, et al.
Publicado: (2023)

Immuno-targeting the multifunctional CD38 using nanobody
por: Li, Ting, et al.
Publicado: (2016)

Comprehensive Proteomics Analysis Identifies CD38-Mediated NAD(+) Decline Orchestrating Renal Fibrosis in Pediatric Patients With Obstructive Nephropathy
por: Tao, Yuandong, et al.
Publicado: (2023)

CD38 ecto-enzyme in immune cells is induced during aging regulating NAD(+) and NMN levels
por: Chini, Claudia C.S., et al.
Publicado: (2020)

Interplay between human STING genotype and bacterial NADase activity regulates inter-individual disease variability
por: Movert, Elin, et al.
Publicado: (2023)

Structure‐based design, synthesis and biological evaluation of a NAD (+) analogue targeting Pseudomonas aeruginosa NAD kinase
por: Rahimova, Rahila, et al.
Publicado: (2022)

Deletion of CD38 and supplementation of NAD(+) attenuate axon degeneration in a mouse facial nerve axotomy model
por: Takaso, Yuji, et al.
Publicado: (2020)

TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity
por: Ugamraj, Harshad S., et al.
Publicado: (2022)

NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates
por: Tatsuno, Ichiro, et al.
Publicado: (2010)

Investigation of the action of poly(ADP-ribose)-synthesising enzymes on NAD(+) analogues
por: Wallrodt, Sarah, et al.
Publicado: (2017)

CD38 Deficiency Alleviates D-Galactose-Induced Myocardial Cell Senescence Through NAD(+)/Sirt1 Signaling Pathway
por: Wang, Ling-Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ue6875joag9cbo09sks9ei30tr